There are no reports on the outcomes of clippings in patients who receive immunosuppressants, for example, due to connective tissue diseases or following organ transplantation. We thoroughly reviewed these cases focusing on the perioperative management phase. The study included 11 patients with intracranial aneurysms who were taking immunosuppressants; between 2007 and 2014. We performed 12 cli...

Beginning in 1967, our laboratory has published a number of investigations of the nonsyngeneic stem ceil-inactivation phenomenon (1-3). I t has been shown that, after transplantation of a mixture of allogeneic lymphoid and hemopoietic cells into lethally irradiated hosts, stem elements of the mixture are inactivated by allogenic lymphocytes of the graft. In other words, after transplantation of...

Infections are frequent and can be severe in recipients of solid organ transplantation. Prevention and treatment are priority objectives of multidisciplinary transplant teams. Interactions between antimicrobials (indicated for prevention and therapy) and immunosuppressants (for preventing rejection) make treatment more complex than in the general population. Co-administration of immunosuppressa...

mycophenolate mofetil (mmf) has been registered for use in australia since 1997 for prophylaxis of solid organ allograft rejection. mmf is now increasingly used for indications outside solid organ allograft rejection, often with limited supporting efficacy data. the purpose of this audit was to examine the patterns of use, reported side effects and cost impact of the drug in the clinical and im...

We report a case of disseminated sporotrichosis in a 49-year-old man who was treated with multiple immunosuppressants, including tumor necrosis factor (TNF)-alpha antagonists (etanercept and infliximab), for presumed inflammation arthritis. This case illustrates the potential for infectious complications related to the use of cytotoxic immunosuppressants and anticytokine agents, such as TNF-alp...